原島 秀吉 | 北大院・薬学研究科

スポンサーリンク

概要

• Harashima Hideyoshiの詳細を見る
• 同名の論文著者
• 北大院・薬学研究科の論文著者

関連著者

• 原島 秀吉

  北大院・薬学研究科

• Harashima Hideyoshi

  Department Of Pharmacokinetics And Pharmaceutics Graduate School Of Pharmaceutical Sciences The Univ

• Kamiya Hiroyuki

  産業医科大学産業生態科学研究所

• Murata-kamiya Naoko

  Inst. Indust. Ecolog. Sci. Univ. Occup. Environ. Hith.

• Shim Chang

  Faculty Of Pharmaceutical Sciences University Of Tokyo : (present Address) College Of Pharmacy Seoul

• Kamiya Hiroyuki

  Faculty of Pharmaceutical Sciences, Hokkaido University

• SHIGENOBU Kohki

  Faculty of Pharmaceutical Sciences, University of Tokyo

• Kasai Hiroshi

  Inst. Of Industrial Ecological Sciences Univ. Of Occupational And Environmental Health 1-1 Iseigaoka

• 際田 弘志

  徳島大学大学院ヘルスバイオサイエンス研究部

• Kiwada H

  Faculty Of Pharmaceutical Sciences Tokushima University

• Akita Hidetaka

  Graduate School Of Pharmaceutical Sciences Hokkaido University

• Akita Hidetaka

  Lab. For Molecular Design Of Pharmaceutics Fac. Of Pharmaceutical Sciences Hokkaido Univ.

• Kiwada Hiroshi

  Department Of Pharmacokinetics And Biopharmaceutics Faculty Of Pharmaceutical Sciences The Universit

• Kamiya Hiroyuki

  Lab. For Molecular Design Of Pharmaceutics Fac. Of Pharmaceutical Sciences Hokkaido Univ.

• Kiwada Hiroshi

  徳島大学 ヘルスバイオサイエンス研究部薬物動態制御学

• Kiwada Hiroshi

  Faculty Of Pharmaceutifal Sciences The University Of Tokushima

• 原島 秀吉

  徳島大学薬学部

• Kamada Haruhiko

  医薬基盤研究所 創薬プロテオミクスプロジェクト

• 原島 秀吉

  北海道大学大学院薬学研究院

• 原島 秀吉

  北大院・薬

• 際田 弘志

  徳島大学薬学部

• 梶本 和昭

  北海道大学大学院薬学研究院

• 際田 弘志

  徳島大・薬

• 篠原 康雄

  徳島大・薬

• 篠原 康雄

  徳島大学・ゲノム機能研究センター

• 篠原 康雄

  徳島大学疾患ゲノム研究センター

• Yamada Yuma

  Lab. For Molecular Design Of Pharmaceutics Fac. Of Pharmaceutical Sciences Hokkaido Univ.

• Yamada Yuma

  Laboratory For Molecular Design Of Pharmaceutics Faculty Of Pharmaceutical Sciences Hokkaido Univers

• Kogure Kentaro

  Dep. Of Biophysical Chemistry Kyoto Pharmaceutical Univ.

• HARASHIMA Hideyoshi

  Graduate School of Pharmaceutical Sciences, Hokkaido University

• Kiwada Hiroshi

  Department Of Pharmacokinetics And Biopharmaceutics Subdivision Of Biopharmaceutical Sciences Instit

• 原島 秀吉

  北大院薬

• Hori Mika

  北海道大学 薬学研究科

• Hori Mika

  北海道大学 薬学研究院

• Hori Mika

  Hokkaido University Graduate School Of Pharmaceutical Sciences

• HARASHIMA Hideyoshi

  Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido Unive

• Baba Yoshinobu

  Department Of Applied Chemistry Graduate School Of Engineering Mext Innovative Research Center For P

• Harashima Hideyoshi

  Laboratory For Molecular Design Of Pharmaceutics Faculty Of Pharmaceutical Sciences Hokkaido Univers

• KAMIYA Hiroyuki

  Graduate School of Pharmaceutical Sciences, Hokkaido University

• Harashima Hideyoshi

  Faculty of Pharmaceutical Sciences, Hokkaido University

• 紙谷 浩之

  北大院・薬学研究科

• 橘 理恵子

  徳島大・薬

• 石田 竜弘

  徳島大学大学院ヘルスバイオサイエンス研究部

• 馬場 嘉信

  徳島大学薬学部薬品物理化学教室

• Baba Yoshinobu

  Dep. Of Applied Chemistry Graduate School Of Engineering Nagoya Univ.

• Hayashi Yasuhiro

  Laboratory of Innovative Nanomedicine, Graduate School of Pharmaceutical Sciences, Hokkaido Universi

• Kaji Noritada

  Department of Applied Chemistry, Graduate School of Engineering, Nagoya University

• Kaji Noritada

  Mext Innovative Res. Center For Preventive Medical Engineering Nagoya Univ.

• 紙谷 浩之

  北大院・薬

• 菊池 寛

  第一製薬株式会社・創剤代謝研究所

• 小暮 健太朗

  北大院・薬

• 土橋 麻理

  徳島大学薬学部

• 原島 秀吉

  徳島大・薬

• Sato Y

  Faculty Of Pharmaceutical Sciences The University Of Tokushima

• Baba Yoshinobu

  Department Of Applied Chemistry Graduate School Of Engineering Nagoya University

• Minakawa Noriaki

  Faculty Of Pharmaceutical Sciences Hokkaido University

• Shinohara Y

  Institute For Genome Research University Of Tokushima:faculty Of Pharmaceutical Sciences University

• Shinohara Yasuo

  Institute For Genome Research University Of Tokushima

• Shinohara Yasuo

  Faculty Of Pharmaceutical Sciences The University Of Tokushima:institute For Genome Research The Uni

• 土橋 麻里

  徳島大学薬学部薬剤学教室

• Iida Shinya

  Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido Unive

• Sato Yuichiro

  Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido Unive

• Kamiya Hiroyuki

  Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido Unive

• Shinohara Yasuo

  Faculty Of Pharmaceutical Sciences University Of Tokushima

• 菊池 寛

  第一製薬(株)研究開発本部創剤代謝研究所

• 原島 秀吉

  北海道大学 大学院薬学研究科医療薬学専攻薬剤分子設計学分野

• 小林 友貴

  徳島大・薬

• 岡田 百合絵

  徳島大・薬

• 石田 竜弘

  徳島大・薬

• 曽根 三郎

  徳島大・医

• 丸山 一雄

  帝京大・薬

• 橘 理恵子

  徳島大薬

• 鈴木 則男

  第一製薬

• 篠原 康雄

  徳島大薬

• 原島 秀吉

  北大薬

• 際田 弘志

  徳島大薬

• 篠原 康雄

  徳島大学薬学部薬剤学教室

• 小島 弘子

  徳島大学薬学部薬剤学教室

• 石田 竜弘

  徳島大学薬学部薬剤学教室

• 丸山 一雄

  帝京大学薬学部

• 丸山 一雄

  帝京大学薬学部薬剤

• 丸山 一雄

  北海道大学 大学院薬学研究科医療薬学専攻医療薬学講座薬剤分子設計学分野

• Ito M

  Meijo Univ. Nagoya Jpn

• Ito M

  Graduate School Of Pharmaceutical Sciences Kyoto University

• Ito M

  Department Of Pharmacognosy Graduate School Of Pharmaceutical Sciences Kyoto University

• Kamada Hitoshi

  Institute For Life Support Technology Yamagata Promotional Organization For Industrial Technology

• SAWADA Akihiro

  Department of Radiology, Saga Medical School

• Sawada Akihiro

  Department Of Applied Chemistry Graduate School Of Engineering Nagoya University

• Tsuchiya Hiroyuki

  Division Of Molecular And Genetic Medicine Department Of Genetic Medicine And Regenerative Therapeut

• Tsuchiya Hiroyuki

  Graduate School Of Pharmaceutical Sciences Hokkaido University:crest Japan Science And Technology

• Kajimoto Kazuaki

  Laboratory of Innovative Nanomedicine, Graduate School of Pharmaceutical Sciences, Hokkaido Universi

• NAKAYA Akihiro

  Department of Computational Biology, University of Tokyo

• Nakaya Akihiro

  Department Of Computational Biology University Of Tokyo

• Ito Mana

  Faculty of Pharmaceutical Sciences, Hokkaido University

• Akita Hidetaka

  Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido Unive

• Tsuchiya Hiroyuki

  Graduate School Of Chemistry Meisei University

• ISHIGURO Chieko

  Graduate School of Pharmaceutical Sciences, Hokkaido University

• HORI Mika

  Graduate School of Pharmaceutical Sciences, Hokkaido University

• ASANUMA Taketoshi

  Graduate School of Veterinary Medicine, Hokkaido University

• INANAMI Osamu

  Graduate School of Veterinary Medicine, Hokkaido University

• KUWABARA Mikinori

  Graduate School of Veterinary Medicine, Hokkaido University

• 秋田 英万

  北海道大学大学院薬学研究院

• Ishida Tatsuhiro

  Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Inst

• Kiwada Hiroshi

  Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Inst

• 東 龍太郎

  大鵬薬品代謝分析研

• 永山 績夫

  大鵬薬品

• EL-SAYED Ayman

  北大院・薬

• KHALIL Ikramy

  北大院・薬

• 小野 耕平

  北大院・薬

• 森口 留美子

  北大院・薬

• 中村 孝司

  北大院・薬

• 山田 勇麿

  北大院・薬学研究科

• 秋田 英万

  北大院・薬学研究科

• 篠原 康雄

  徳大・ゲノム機能研究センター

• 小林 英夫

  第一製薬株式会社・創剤代謝研究所

• 原島 秀吉

  北海道大・薬

• 原島 秀吉

  北海道大院・薬

• 馬場 嘉信

  徳島大薬

• 浮津 佐知子

  徳島大薬

• 土井 久子

  徳島大学薬学部

• 井手 奈保子

  徳島大・薬

• 宗像 達夫

  徳島大学海洋環境資源学教室

• 山田 みづき

  徳島大・薬

• 菊石 純也

  徳島大・薬

• 河野 友昭

  徳島大・薬

• 柳田 志穂

  徳島大・薬

• 根本 尚夫

  徳島大・薬

• 渋谷 雅之

  徳島大・薬

• 橘 理恵子

  徳島大学薬学部

• 太田 慈子

  徳島大学薬学部

• 庄野 正行

  徳島大学医学部

• 二木 史郎

  徳島大学薬学部

• 増田 佳子

  徳島大学薬学部薬剤学教室

• 土橋 麻理

  徳島大・薬

• 飯田 慎也

  徳島大・薬

• 島田 貴浩

  徳島大学薬学部薬剤学教室

• 鈴木 亮佑

  北大院・薬

• 山田 勇磨

  北大院・薬

• 浅沼 武敏

  北海道大学大学院獣医学研究科環境獣医科学講座放射線学教室

• 花岡 文雄

  大阪大学大学院生命機能研究科 細胞構造研究室

• 飯田 慎也

  北大院 薬学研究科

• 渋谷 雅之

  徳島大薬

• 渋谷 雅之

  徳島大学薬学部

• 佐藤 和哉

  北大・院・薬

• ASAI Tomohiro

  Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine, Dentistry, and

• OKU Naoto

  Department of Radiobiochemistry, School of Pharmaceutical Sciences, University of Shizuoka

• Oku Naoto

  タイ

• 永山 績夫

  大鵬薬品・育薬研究所

• 東 龍太郎

  大鵬薬品工業代謝分析研

• 川口 安郎

  大鵬薬品・代謝分析研

• 益谷 央豪

  大阪大学

• 土谷 博之

  北大院薬

• KASAI HIROSHI

  Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health

• Ito Michiho

  北里大学 薬学部

• 佐藤 和哉

  北大院・薬

• 益谷 央豪

  阪大院・生命機能

• 花岡 文雄

  阪大院・生命機能

• KOBAYASHI Hideo

  Drug Metabolism & Physicochemistry Research Laboratory, Tokyo R&D Center, Daiichi Pharmaceutical Co.

• HASHIMOTO Kouichi

  Drug Metabolism & Physicochemistry Research Laboratory, Tokyo R&D Center, Daiichi Pharmaceutical Co.

• KIKUCHI Hiroshi

  Drug Metabolism & Physicochemistry Research Laboratory, Tokyo R&D Center, Daiichi Pharmaceutical Co.

• ATOBE Kazutaka

  Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Inst

• ISHIDA Emi

  Drug Metabolism and Physicochemistry Research Laboratory, R&D Division, Daiichi Pharmaceutical Co.,

• YASUDA Jyunko

  Daiichi Fine Chemical Co.. Ltd.

• AOKI Takanori

  Daiichi Fine Chemical Co.. Ltd.

• OBATA Ken-ichi

  Daiichi Fine Chemical Co.. Ltd.

• AKITA Hidetaka

  Graduate School of Pharmaceutical Sciences, Hokkaido University

• 東 龍太郎

  大鵬薬品・代謝分析研

• 小室 昌仁

  大鵬薬品・代謝分析研

• Oku Naoto

  Department Of Medical Biochemistry And Coe Program In The 21st Century University Of Shizuoka School

• Asai Tomohiro

  Department Of Cardiovascular Surgery Okayama University Graduate School Of Medicine Dentistry And Ph

• Asai Tomohiro

  Department Of Medical Biochemistry And Coe Program In The 21st Century University Of Shizuoka School

• Nakabeppu Yusaku

  Medical Institute Of Bioregulation Kyushu University

• Yamashita Kikuji

  Institute of Health Biosciences

• Shinohara Yasuo

  Institute for Genome Research

• 山崎 淳

  北大・院・薬

• 桑田 慶三

  大鵬薬品工業代謝分析研

• 山崎 淳

  北大院・薬

• 桑田 慶三

  大鵬薬品・代謝分析研

• 土谷 博之

  北大院・薬

• 浮津 佐知子

  徳島大・薬

• CADENA-AMARO Claudio

  Unite de Chimie Organique, URA CNRS 2128, Institut Pasteur

• DUGUE Laurence

  Unite de Chimie Organique, URA CNRS 2128, Institut Pasteur

• YAKUSHIJI Hiroyuki

  Medical Institute of Bioregulation, Kyushu University

• MATSUDA Akira

  Faculty of Pharmaceutical Sciences, Hokkaido University

• POCHET Sylvie

  Unite de Chimie Organique, URA CNRS 2128, Institut Pasteur

• Ymamoto Takenori

  Institute For Genome Research

• Matsuda Akira

  Graduate School of Pharmaceutical Sciences, Hokkaido University

• KANAMURA Kiyoshi

  TTI ellebeau Inc.

• NAGATA Hideya

  Health Technology Research Center, National Institute of Advanced Industrial Science and Technology

• Mizufune Shogo

  Department of Applied Chemistry, Graduate School of Engineering, Nagoya University

• Satou Kazuya

  Faculty of Pharmaceutical Sciences, Hokkaido University

• Suda Yusuke

  Faculty of Pharmaceutical Sciences, Hokkaido University

• SAWAMURA Tomoko

  Graduate School of Pharmaceutical Sciences, Hokkaido University

• KARINO Naoko

  Graduate School of Pharmaceutical Sciences, Hokkaido University

• UENO Yoshihito

  Graduate School of Pharmaceutical Sciences, Hokkaido University

• Yamauchi Jun

  Laboratory of Innovative Nanomedicine, Graduate School of Pharmaceutical Sciences, Hokkaido Universi

• Nagata Hideya

  Health Technology Research Center National Institute Of Advanced Industrial Science And Technology (

• Nagata Hideya

  Health Technology Research Center National Institute Of Advanced Industrial Sciences And Technology

• 島田 貴浩

  徳島大・薬

• Sawamura Tomoko

  Graduate School Of Pharmaceutical Sciences Hokkaido University

もっと見る 閉じる

著作論文

• Transgene expression efficiency from plasmid DNA delivered as a complex with histone H3
• Suppression of mutagenesis by 8-hydroxy-2'-deoxyguanosine 5'-triphosphate (7,8-dihydro-8-oxo-2'-deoxyguanosine 5'-triphosphate) by human MTH1, MTH2, and NUDT5
• Isolation and culture of microvascular endothelial cells from murine inguinal and epididymal adipose tissues
• Base excision repair enzyme endonuclease III suppresses mutagenesis caused by 8-hydroxy-dGTP
• UvrA and UvrB enhance mutations induced by oxidized deoxyribonucleotides
• Effects of Overexpression and Antisense RNA Expression of Orf17, a MutT-Type Enzyme
• Increased A:T→C:G Mutations in the mutT Strain upon 8-Hydroxy-dGTP Treatment : Direct Evidence for MutT Involvement in the Prevention of Mutations by Oxidized dGTP
• Effects of base excision repair proteins on mutagenesis by 8-oxo-7,8-dihydroguanine (8-hydroxyguanine) paired with cytosine and adenine
• Roles of specialized DNA polymerases in mutagenesis by 8-hydroxyguanine in human cells
• 補体活性化に及ぼすリポソームの変動要因に関する研究 : 粒子径, コレステロールの水酸基側鎖長の影響
• Comparison between a Multifunctional Envelope-Type Nano Device and Lipoplex for Delivery to the Liver
• Stepwise dissection of the Mechanism of Macropinosomal Escape for Octaarginine Modified Nanoparticles
• オクタアルギニン修飾リポソームによるMHCクラスI特異的抗原デリバリーメカニズムの解析
• ミトコンドリアを標的としたDDSと疾患治療への応用 : ミトコンドリア融合性リポソーム、"MITO-Porter" を用いたアプローチ
• イムノリポソームの膜流動性の差が及ぼす殺細胞効果と細胞内取り込み量への影響
• PK/PDを基盤とするDDS
• 細胞内動態制御のためのインテリジェント素子の開発 : GALAとNLSによるエンドソーム膜・核膜バリアーの突破
• トランスフェリン修飾リポソームを用いたP-gpによる抗癌剤排出回避の試み
• 人工ベクターによる導入遺伝子の核内移行及び発現メカニズム(2)
• 人工ベクターによる導入遺伝子の核内移行及び発現メカニズム(1)
• 血中滞留性リポソームによる抗癌剤の処方設計における最適化
• 物理化学的視点からみた薬物の分布 (特集 物理化学的視点から医薬品をみる--化学構造・物性を臨床に活かすために)
• リポソームによる細胞内動態制御法の構築
• 人工遺伝子ベクターによる遺伝子の細胞内動態の解明 : 遺伝子の核内送達量と発現の定量的評価
• 核局在化シグナルによる遺伝子の核内送達促進は可能か?
• キャリアによる細胞内デリバリー戦略と今後の課題
• 血中滞留性リポソーム封入ドキソルビシンの腹腔癌における抗腫瘍効果制御システムの構築
• コレステロール修飾による補体回避型リポソームの開発
• リポソームによる高分子医薬品の細胞内動態制御法に関する研究(1)
• Liposome封入薬物の肝臓内動態に関する研究
• シミュレーションによるリポソーム封入ドキソルビシンの抗腫瘍効果決定因子の探索
• リポソーム膜中のコレステロール含量が及ぼす補体第3成分(C3)の結合と体内動態への影響
• In vivo 実験系による異種リポソーム間の肝取込における競合機構の解明
• 多機能性エンベロープ型ナノ構造体(MEND)を用いたタンパク質の効率的な細胞質送達
• Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue
• P-56 DNAポリメラーゼη欠損細胞抽出液によるDNA複製における8-hydroxy-dGTPの誘発変異(ポスター(2))
• MITO-Porter : a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion
• In Vitro Efficacy of a Sterically Stabilized Immunoliposomes Targeted to Membrane Type 1 Matrix Metalloproteinase (MT1-MMP)(Biopharmacy)
• Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis
• 外来DNAのトポロジー, サイズの転写効率への影響
• TAS-102経口投与におけるヒトFTD代謝の予測
• Recognition of Nucleotide Analogs Containing the 7,8-Dihydro-8-oxo Structure by the Human MTH1 Protein
• New NTP analogs: the synthesis of 4'-thioUTP and 4'-thioCTP and their utility for SELEX
• DNA Microarray Analysis of Whole Blood Cells and Insulin-Sensitive Tissues Reveals the Usefulness of Blood RNA Profiling as a Source of Markers for Predicting Type 2 Diabetes
• DNA Microarray Analysis of Type 2 Diabetes-Related Genes Co-regulated between White Blood Cells and Livers of Diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) Rats
• NUDT5 hydrolyzes oxidized deoxyribonucleoside diphosphates with broad substrate specificity
• Involvement of specialized DNA polymerases in mutagenesis by 8-hydroxy-dGTP in human cells
• Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide
• Mutagenic effects of 8-hydroxy-dGTP in live mammalian cells
• Induction of Substitution and Deletion Mutations by 2-Hydroxyadenine during Replication in a HeLa Extract
• Incorporation of 8-hydroxyguanosine (8-oxo-7,8-dihydroguanosine) 5'-triphosphate by bacterial and human RNA polymerases
• Genome Wide Expression Analysis of White Blood Cells and Liver of Pre-diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) Rats Using a cDNA Microarray
• Cytotoxic Effect of Drosophila Deoxynucleoside Kinase Gene on Replicating Plasmid in HeLa Cells
• Induction of Various Mutations during PCRs with Manganese and 8-Hydroxy-dGTP
• PK-PD modeling of 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine and the enhanced antitumor effect of its phospholipid derivatives in long-circulating liposomes
• Correction of Frameshift Mutations with Single-Stranded and Double-Stranded DNA Fragments Prepared from Phagemid/Plasmid DNAs(Miscellaneous)
• RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells
• Mutagenicity of 5-Formylcytosine, an Oxidation Product of 5-Methylcytosine, in DNA in Mammalian Cells
• Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes
• Cell cycle dependent transcription, a determinant factor of heterogeneity in cationic lipid-mediated transgene expression.
• Effects of 8-hydroxy-GTP and 2-hydroxy-ATP on in vitro transcription.
• Novel lipidated sorbitol-based molecular transporters for non-viral gene delivery
• Efficient Short Interference RNA Delivery to Tumor Cells Using a Combination of Octaarginine, GALA and Tumor-Specific, Cleavable Polyethylene Glycol System
• Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid
• A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system
• Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
• Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake
• Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA
• Unexpectedly weak impacts of decreased p53 and retinoblastoma protein levels on mutagenesis by 8-oxo-7,8-dihydroguanine (8-hydroxyguanine)
• Cell penetrating peptide-mediated systemic siRNA delivery to the liver
• Unexpectedly Weak Impacts of Decreased p53 and Retinoblastoma Protein Levels on Mutagenesis by 8-Oxo-7, 8-dihydroguanine (8-Hydroxyguanine)
• Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery
• Effects of insulator cHS4 on transgene expression from plasmid DNA in a positive feedback system(GENETICS, MOLECULAR BIOLOGY, AND GENE ENGINEERING)
• A DNA Microarray-based Analysis of the Host Response to a Nonviral Gene Carrier: A Strategy for Improving the Immune Response
• Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy.
• CREB-binding protein transcription activation domain for enhanced transgene expression by a positive feedback system
• Intracellular stability of 2'-OMe-4'-thioribonucleoside modified siRNA leads to long-term RNAi effect
• Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy
• Pretreatment of Hepatocyte Growth Factor Gene Transfer Mediated by Octaarginine Peptide-Modified Nanoparticles Ameliorates LPS/D-Galactosamine-Induced Hepatitis
• Vascular-targeted nanotherapy for obesity: Unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery
• A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo

もっと見る 閉じる

スポンサーリンク